Olivier Bouché
Service d'Hépatogastroentérologie et de Cancérologie Digestive
CHU Robert Debré
51092 REIMS CEDEX
France
Name/email consistency: high
- Phase II Trial of Weekly Alternating Sequential BIBF 1120 and Afatinib for Advanced Colorectal Cancer. Bouche, O., Maindrault-Goebel, F., Ducreux, M., Lledo, G., Andre, T., Stopfer, P., Amellal, N., Merger, M., DE Gramont, A. Anticancer Res. (2011)
- The role of anti-epidermal growth factor receptor monoclonal antibody monotherapy in the treatment of metastatic colorectal cancer. Bouché, O., Beretta, G.D., Alfonso, P.G., Geissler, M. Cancer Treat. Rev. (2010)
- Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801). Bouché, O., Ychou, M., Burtin, P., Bedenne, L., Ducreux, M., Lebreton, G., Baulieux, J., Nordlinger, B., Martin, C., Seitz, J.F., Tigaud, J.M., Echinard, E., Stremsdoerfer, N., Milan, C., Rougier, P. Ann. Oncol. (2005)
- Randomized multicenter phase II trial of a biweekly regimen of fluorouracil and leucovorin (LV5FU2), LV5FU2 plus cisplatin, or LV5FU2 plus irinotecan in patients with previously untreated metastatic gastric cancer: a Federation Francophone de Cancerologie Digestive Group Study--FFCD 9803. Bouché, O., Raoul, J.L., Bonnetain, F., Giovannini, M., Etienne, P.L., Lledo, G., Arsène, D., Paitel, J.F., Guérin-Meyer, V., Mitry, E., Buecher, B., Kaminsky, M.C., Seitz, J.F., Rougier, P., Bedenne, L., Milan, C. J. Clin. Oncol. (2004)









